Last 12 months
Inside the activity.
1 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,383 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003817 · doc4.xml · derivative · entry 3 Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,383 Underlying: Common Stock, $.01 Par Value · 2,383 shares Expires 2030-02-26 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
|
GrantCommon Stock, $.01 Par Value | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003817 · doc4.xml · nonDerivative · entry 1 Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,096 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Sadler Jason DPres., International Markets
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,007 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003816 · doc4.xml · derivative · entry 2 Sadler Jason D · CIK 0001554974 · Pres., International Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,007 Underlying: Common Stock, $.01 Par Value · 9,007 shares Expires 2030-02-26 F2 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Sadler Jason DPres., International Markets
|
GrantCommon Stock, $.01 Par Value | 2,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003816 · doc4.xml · nonDerivative · entry 1 Sadler Jason D · CIK 0001554974 · Pres., International Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,098 F1 · shares: These restricted stock units vest in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
WENTWORTH TIMOTHY CPresident, Health Services
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 28,594 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003815 · doc4.xml · derivative · entry 3 WENTWORTH TIMOTHY C · CIK 0001252016 · President, Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,594 Underlying: Common Stock, $.01 Par Value · 28,594 shares Expires 2030-02-26 F2 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
WENTWORTH TIMOTHY CPresident, Health Services
|
GrantCommon Stock, $.01 Par Value | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003815 · doc4.xml · nonDerivative · entry 1 WENTWORTH TIMOTHY C · CIK 0001252016 · President, Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,186 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Palmer Eric PEVP, Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,016 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003813 · doc4.xml · derivative · entry 4 Palmer Eric P · CIK 0001710190 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,016 Underlying: Common Stock, $.01 Par Value · 20,016 shares Expires 2030-02-26 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Palmer Eric PEVP, Chief Financial Officer
|
GrantCommon Stock, $.01 Par Value | 5,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003813 · doc4.xml · nonDerivative · entry 1 Palmer Eric P · CIK 0001710190 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,816 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Triplett Michael WPresident, US Markets
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 10,008 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003814 · doc4.xml · derivative · entry 3 Triplett Michael W · CIK 0001698840 · President, US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,008 Underlying: Common Stock, $.01 Par Value · 10,008 shares Expires 2030-02-26 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Triplett Michael WPresident, US Markets
|
GrantCommon Stock, $.01 Par Value | 2,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003814 · doc4.xml · nonDerivative · entry 1 Triplett Michael W · CIK 0001698840 · President, US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,828 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Miller Steven BEVP, Chief Clinical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,243 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003811 · doc4.xml · derivative · entry 2 Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,243 Underlying: Common Stock, $.01 Par Value · 5,243 shares Expires 2030-02-26 F2 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Miller Steven BEVP, Chief Clinical Officer
|
GrantCommon Stock, $.01 Par Value | 1,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003811 · doc4.xml · nonDerivative · entry 1 Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,359 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Manders Matthew GPresident, Strategy & Solution
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,586 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003810 · doc4.xml · derivative · entry 2 Manders Matthew G · CIK 0001480601 · President, Strategy & Solution 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,586 Underlying: Common Stock, $.01 Par Value · 18,586 shares Expires 2030-02-26 F2 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Manders Matthew GPresident, Strategy & Solution
|
GrantCommon Stock, $.01 Par Value | 5,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003810 · doc4.xml · nonDerivative · entry 1 Manders Matthew G · CIK 0001480601 · President, Strategy & Solution 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,566 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Jones Nicole SEVP, General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,346 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003809 · doc4.xml · derivative · entry 3 Jones Nicole S · CIK 0001492663 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,346 Underlying: Common Stock, $.01 Par Value · 15,346 shares Expires 2030-02-26 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Jones Nicole SEVP, General Counsel
|
GrantCommon Stock, $.01 Par Value | 4,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003809 · doc4.xml · nonDerivative · entry 1 Jones Nicole S · CIK 0001492663 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,266 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Evanko Brian CPresident Government Business
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 12,010 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003808 · doc4.xml · derivative · entry 3 Evanko Brian C · CIK 0001722909 · President Government Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,010 Underlying: Common Stock, $.01 Par Value · 12,010 shares Expires 2030-02-26 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:27 UTC |
Evanko Brian CPresident Government Business
|
GrantCommon Stock, $.01 Par Value | 3,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003808 · doc4.xml · nonDerivative · entry 1 Evanko Brian C · CIK 0001722909 · President Government Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,844 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:26 UTC |
Cordani DavidDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 66,718 | $0.00 Strike: $192.02 | $0.00 |
DisclosureSEC source: 0001225208-20-003807 · doc4.xml · derivative · entry 4 Cordani David · CIK 0001318751 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,718 Underlying: Common Stock, $.01 Par Value · 66,718 shares Expires 2030-02-26 F4 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 02:26 UTC |
Cordani DavidDirector · President & CEO
|
GrantCommon Stock, $.01 Par Value | 18,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003807 · doc4.xml · nonDerivative · entry 1 Cordani David · CIK 0001318751 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,627 F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021. F2 · balance_after: Reflects a transfer by the Reporting Person of 337,515 shares of common stock to a grantor retained annuity trust on September 13, 2019. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 17:35 UTC |
MURABITO JOHN MEVP, HR & Services
|
SaleCommon Stock, $.01 Par Value | 10,000 | $209.00 | $2,090,000.00 |
DisclosureSEC source: 0001225208-20-003583 · doc4.xml · nonDerivative · entry 1 MURABITO JOHN M · CIK 0001126222 · EVP, HR & Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,969 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:07 UTC |
Miller Steven BEVP, Chief Clinical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,406 | $0.00 Strike: $121.14 | $0.00 |
DisclosureSEC source: 0001225208-20-002233 · doc4.xml · derivative · entry 3 Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 8,406 shares Expires 2020-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on March 6, 2013. The option vested in three equal annual installments on February 28, 2014, February 28, 2015 and February 28, 2016. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:07 UTC |
Miller Steven BEVP, Chief Clinical Officer
|
SaleCommon Stock, $.01 Par Value | 7,145 | $212.15 | $1,515,838.90 |
DisclosureSEC source: 0001225208-20-002233 · doc4.xml · nonDerivative · entry 2 Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,926 F1 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $211.546 to $212.46 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 23:07 UTC |
Miller Steven BEVP, Chief Clinical Officer
|
Exercise / conversionCommon Stock, $.01 Par Value | 8,406 | $121.14 | $1,018,278.46 |
DisclosureSEC source: 0001225208-20-002233 · doc4.xml · nonDerivative · entry 1 Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:39 UTC |
DeLaney William J IIIDirector
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,819 | $0.00 Strike: $128.24 | $0.00 |
DisclosureSEC source: 0001225208-20-002220 · doc4.xml · derivative · entry 4 DeLaney William J III · CIK 0001384151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 2,819 shares Expires 2020-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 9, 2013 and vested annually in three equal installments. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:39 UTC |
DeLaney William J IIIDirector
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,074 | $0.00 Strike: $139.63 | $0.00 |
DisclosureSEC source: 0001225208-20-002220 · doc4.xml · derivative · entry 3 DeLaney William J III · CIK 0001384151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 3,074 shares Expires 2021-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on May 7, 2014 and vested annually in three equal installments. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:39 UTC |
DeLaney William J IIIDirector
|
Exercise / conversionCommon Stock, $.01 Par Value | 2,819 | $128.24 | $361,503.77 |
DisclosureSEC source: 0001225208-20-002220 · doc4.xml · nonDerivative · entry 2 DeLaney William J III · CIK 0001384151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:39 UTC |
DeLaney William J IIIDirector
|
Exercise / conversionCommon Stock, $.01 Par Value | 3,074 | $139.63 | $429,220.78 |
DisclosureSEC source: 0001225208-20-002220 · doc4.xml · nonDerivative · entry 1 DeLaney William J III · CIK 0001384151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 23:06 UTC |
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
|
SaleCommon Stock, $.01 Par Value | 10,298 | $209.57 | $2,158,141.56 |
DisclosureSEC source: 0001225208-20-001962 · doc4.xml · nonDerivative · entry 4 WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 24,230 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2019. F5 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $209.20 to $210.19 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 23:06 UTC |
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
|
SaleCommon Stock, $.01 Par Value | 5,508 | $208.82 | $1,150,203.14 |
DisclosureSEC source: 0001225208-20-001962 · doc4.xml · nonDerivative · entry 3 WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 34,528 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2019. F4 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $208.20 to $209.195 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 23:06 UTC |
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
|
SaleCommon Stock, $.01 Par Value | 5,302 | $210.78 | $1,117,546.55 |
DisclosureSEC source: 0001225208-20-001962 · doc4.xml · nonDerivative · entry 2 WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 40,036 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2019. F3 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $210.22 to $211.19 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 23:06 UTC |
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
|
SaleCommon Stock, $.01 Par Value | 600 | $211.60 | $126,960.36 |
DisclosureSEC source: 0001225208-20-001962 · doc4.xml · nonDerivative · entry 1 WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 45,338 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2019. F2 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $211.23 to $212.12 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 22:16 UTC |
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
|
Tax withholdingCommon Stock, $.01 Par Value | 3,910 | $196.31 | $767,572.10 |
DisclosureSEC source: 0001225208-20-001788 · doc4.xml · nonDerivative · entry 2 WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,374 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| January 23, 2020 Filed Feb 6, 2020 22:16 UTC |
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
|
GiftCommon Stock, $.01 Par Value | 21,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-001788 · doc4.xml · nonDerivative · entry 3 WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 45,938 Read SEC document |
| January 23, 2020 Filed Feb 6, 2020 22:16 UTC |
WENTWORTH TIMOTHY CPres, Exp Scrpts & Cigna Svcs
|
GiftCommon Stock, $.01 Par Value | 21,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-001788 · doc4.xml · nonDerivative · entry 1 WENTWORTH TIMOTHY C · CIK 0001252016 · Pres, Exp Scrpts & Cigna Svcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,284 Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 22:14 UTC |
Triplett Michael WPresident, US Markets
|
GiftCommon Stock, $.01 Par Value | 225 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015301 · doc4.xml · nonDerivative · entry 1 Triplett Michael W · CIK 0001698840 · President, US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,093 Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 22:26 UTC |
FOSS ERIC JDirector
|
PurchaseCommon Stock, $.01 Par Value | 4,100 | $195.04 | $799,659.90 |
DisclosureSEC source: 0001225208-19-015303 · doc4.xml · nonDerivative · entry 2 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,683 F2 · price: Represents the weighted average price of the shares purchased. The prices actually paid ranged from $194.32 to $195.30 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 22:26 UTC |
FOSS ERIC JDirector
|
PurchaseCommon Stock, $.01 Par Value | 6,100 | $195.66 | $1,193,505.26 |
DisclosureSEC source: 0001225208-19-015303 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,583 F1 · price: Represents the weighted average price of the shares purchased. The prices actually paid ranged from $195.33 to $195.90 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:42 UTC |
WISEMAN ERIC CDirector
|
GrantPhantom Stock Units · Derivative | 135 | $199.92 | $26,989.20 |
DisclosureSEC source: 0001225208-19-015096 · doc4.xml · derivative · entry 2 WISEMAN ERIC C · CIK 0001237851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,795 Underlying: Common Stock, $.01 Par Value · 135 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:42 UTC |
WISEMAN ERIC CDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015096 · doc4.xml · nonDerivative · entry 1 WISEMAN ERIC C · CIK 0001237851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,387 Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 19:41 UTC |
ROPER WILLIAM LDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015094 · doc4.xml · nonDerivative · entry 1 ROPER WILLIAM L · CIK 0001087960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,364 Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:42 UTC |
ZARCONE DONNA FDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015095 · doc4.xml · nonDerivative · entry 1 ZARCONE DONNA F · CIK 0001243083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,800 F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC |
PARTRIDGE JOHNDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015093 · doc4.xml · nonDerivative · entry 1 PARTRIDGE JOHN · CIK 0001319897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,417 Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC |
MAZZARELLA KATHLEEN MDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015091 · doc4.xml · nonDerivative · entry 1 MAZZARELLA KATHLEEN M · CIK 0001273233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,338 Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC |
McClellan Mark B.Director
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015092 · doc4.xml · nonDerivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,338 Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC |
MARTINEZ ROMAN IVDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015090 · doc4.xml · nonDerivative · entry 1 MARTINEZ ROMAN IV · CIK 0001276303 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,846 F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC |
Granger ElderDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015088 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,860 Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC |
FOSS ERIC JDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015087 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,483 Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC |
HARRIS ISAIAH JRDirector · Chairman of the Board
|
GrantCommon Stock, $.01 Par Value | 287 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015089 · doc4.xml · nonDerivative · entry 1 HARRIS ISAIAH JR · CIK 0001202287 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,747 F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC |
DeLaney William J IIIDirector
|
GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015086 · doc4.xml · nonDerivative · entry 1 DeLaney William J III · CIK 0001384151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,120 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.